Articles
Fidia Pharma held a press conference on November 29, 2018 announcing the arrival of Trinov hair growth lotion at pharmacies in Italy. The press release was shared in the news section of Fidia’s website, only in the Italian version of the website. Upon first glance this was good news to read, however when I clicked on…
Read More(Update: Minimum investment in HairClone is now £100) HairClone, a UK based company working on cellular hair restoration therapies, has announced the launch of its public crowdfunding campaign today. Please enjoy the introductory HairClone crowdfunding video below. To launch the campaign HairClone has teamed up with Capital Cell, a European based equity crowdfunding company which specializes…
Read More
Today, I will be sharing some expanded information I have received about the exciting new hair growth cosmetic “NGF-574H” from Medipost of South Korea. Earlier this year in May, I initially covered Medipost’s development of NGF-574H. The product itself is a stem cell-derived serum which has been tailored to be effective at preventing hair loss…
Read More
Updated 2/28/20 Samumed SM04554 Phase 3 Trial Is Now Fully Enrolled In a company newsletter published on February 28, 2020, Samumed announced that their phase 3 trial of SM04454 in AGA has finally reached its quota of trial participants. That quota was a whopping 625 male subjects between the ages of 18 – 45 years…
Read More
(Updated Below) As the company promised to do earlier this month, Follicum has released data from its phase 2a study which concluded in August earlier this year. This was the first trial Follicum conducted using FOL-005, a modified peptide, on human scalps. In this recent scalp study, five doses (including placebo) were evaluated where patients…
Read More
One of the most fascinating companies in the hair restoration industry, HairClone, has been featured in the latest edition of the UK’s Consulting Room online magazine. The article features commentary from HairClone CEO Paul Kemp PhD and Medical Director Dr. Bessam Farjo. The article by Lorna Jackson is very detail oriented and provides a comprehensive…
Read More
According to its latest news update, Follicum will present top-line data from its recent phase 2a trial by the end of the month. The phase 2a trial for Follicum’s hair growth candidate FOL-005 was completed at sites in Hamburg and Berlin, Germany at the end of August this year. The study comprised 60 patients (assumed…
Read More
Updated After a long wait we finally have the answer. The “Brotzu Lotion” aka Trinov is going to be released by Fidia Pharma this year. The press release shown above was posted on Fidia’s official website today only in the Italian version. The key points from the announcement are as follows: Production on Trinov has…
Read More
British hair-cell cloning company HairClone has released its latest newsletter on September 10th. This is the second newsletter of the year from HairClone, the company previously published a newsletter in February. HairClone typically divides its news updates into two categories, business and science. It’s interesting to follow HairClone’s progress in these regards and see how…
Read More
The Guardian has reported the intriguing drug WAY-316606, which was originally developed for osteoporosis, may soon be entering human hair growth clinical trials with the help of an Italian pharmaceutical company. I was pleasantly surprised to find some worthwhile information in the latest “mainstream media baldness cure” article published by The Guardian today. I should…
Read More